Myconic Capital Corp News - MEDI

Professional-Grade Tools, for Individual Investors.

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of...

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/...

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

- 10th Consecutive Year for MedImmune on the Fast 50 List - GAITHERSBURG, Md., Sept. 29 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named...

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

GAITHERSBURG, Md., Oct. 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named to Deloitte's Maryland Technology Fast 50 program for the...

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/...

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months NEW ORLEANS, June 6...

No Posts Found

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Myconic Capital Corp (MEDI)

Professional-Grade Tools, for Individual Investors.

MEDI News

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

MEDI Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Myconic Capital Corp (MEDI) News

Myconic Capital Corp (MEDI)

Professional-Grade Tools, for Individual Investors.

MEDI News

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

MEDI Discussion

Your Recent History

Go Ad-Free